Intratumor and informatic heterogeneity influence meningioma molecular classification
Acta Neuropathol
.
2022 Sep;144(3):579-583.
doi: 10.1007/s00401-022-02455-y.
Epub 2022 Jun 27.
Authors
Harish N Vasudevan
1
2
,
Abrar Choudhury
#
1
2
,
Stephanie Hilz
#
2
,
Javier E Villanueva-Meyer
3
,
William C Chen
1
2
,
Calixto-Hope G Lucas
4
,
Steve E Braunstein
1
,
Nancy Ann Oberheim Bush
2
,
Nicholas Butowski
2
5
,
Melike Pekmezci
4
,
Michael W McDermott
6
,
Arie Perry
2
4
,
David A Solomon
4
,
Stephen T Magill
#
7
,
David R Raleigh
#
8
9
Affiliations
1
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
2
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
3
Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
4
Department of Pathology, University of California San Francisco, San Francisco, CA, USA.
5
Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
6
Miami Neuroscience Institute, Baptist Health, Miami, FL, USA.
7
Department of Neurological Surgery, Northwestern University, Chicago, IL, USA. stephen.magill@northwestern.edu.
8
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
9
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. david.raleigh@ucsf.edu.
#
Contributed equally.
PMID:
35759011
PMCID:
PMC9618384
DOI:
10.1007/s00401-022-02455-y
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers, Tumor
Genetic Heterogeneity
Humans
Informatics
Meningeal Neoplasms* / genetics
Meningioma* / genetics
Mutation
Substances
Biomarkers, Tumor
Grants and funding
F30 CA246808/CA/NCI NIH HHS/United States
P50 CA097257/CA/NCI NIH HHS/United States
R01 CA262311/CA/NCI NIH HHS/United States
T32 CA151022/CA/NCI NIH HHS/United States